Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 272

1.

Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma.

Rubinstein PG, Moore PC, Rudek MA, Henry DH, Ramos JC, Ratner L, Reid E, Sharon E, Noy A; AIDS Malignancy Consortium (AMC).

AIDS. 2017 Dec 26. doi: 10.1097/QAD.0000000000001729. [Epub ahead of print]

PMID:
29280762
2.

Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potency.

Albano MS, Ciubotariu R, Dobrila L, Tarnawski M, DeLeon M, Watanabe C, Krishnan S, Scaradavou A, Rubinstein P.

Transfusion. 2017 Nov;57(11):2768-2774. doi: 10.1111/trf.14257. Epub 2017 Jul 31.

PMID:
28758211
3.

Long-term survival in AIDS-related primary central nervous system lymphoma.

Gupta NK, Nolan A, Omuro A, Reid EG, Wang CC, Mannis G, Jaglal M, Chavez JC, Rubinstein PG, Griffin A, Abrams DI, Hwang J, Kaplan LD, Luce JA, Volberding P, Treseler PA, Rubenstein JL.

Neuro Oncol. 2017 Jan;19(1):99-108. doi: 10.1093/neuonc/now155. Epub 2016 Aug 30.

4.

Banking or Bankrupting: Strategies for Sustaining the Economic Future of Public Cord Blood Banks.

Magalon J, Maiers M, Kurtzberg J, Navarrete C, Rubinstein P, Brown C, Schramm C, Larghero J, Katsahian S, Chabannon C, Picard C, Platz A, Schmidt A, Katz G.

PLoS One. 2015 Dec 1;10(12):e0143440. doi: 10.1371/journal.pone.0143440. eCollection 2015.

5.

Low Molecular Weight Fraction of Commercial Human Serum Albumin Induces Morphologic and Transcriptional Changes of Bone Marrow-Derived Mesenchymal Stem Cells.

Bar-Or D, Thomas GW, Rael LT, Gersch ED, Rubinstein P, Brody E.

Stem Cells Transl Med. 2015 Aug;4(8):945-55. doi: 10.5966/sctm.2014-0293. Epub 2015 Jun 3.

6.

How we handled the dextran shortage: an alternative washing or dilution solution for cord blood infusions.

Reich-Slotky R, Bachegowda LS, Ancharski M, Mendeleyeva L, Rubinstein P, Rennert H, Shore T, van Besien K, Cushing M.

Transfusion. 2015 Jun;55(6):1147-53. doi: 10.1111/trf.13015. Epub 2015 Feb 5.

PMID:
25652820
7.

Initial Experience with the Use of Thrombopoetin Receptor Agonists in Patients with Refractory HIV-Associated Immune Thrombocytopenic Purpura: A Case Series.

Kowalczyk M, Rubinstein PG, Aboulafia DM.

J Int Assoc Provid AIDS Care. 2015 May-Jun;14(3):211-6. doi: 10.1177/2325957414557266. Epub 2014 Dec 9.

PMID:
25504472
8.

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.

Reichel J, Chadburn A, Rubinstein PG, Giulino-Roth L, Tam W, Liu Y, Gaiolla R, Eng K, Brody J, Inghirami G, Carlo-Stella C, Santoro A, Rahal D, Totonchy J, Elemento O, Cesarman E, Roshal M.

Blood. 2015 Feb 12;125(7):1061-72. doi: 10.1182/blood-2014-11-610436. Epub 2014 Dec 8.

9.

Noninherited maternal antigens identify acceptable HLA mismatches: benefit to patients and cost-effectiveness for cord blood banks.

Van der Zanden HG, Van Rood JJ, Oudshoorn M, Bakker JN, Melis A, Brand A, Scaradavou A, Rubinstein P.

Biol Blood Marrow Transplant. 2014 Nov;20(11):1791-5. doi: 10.1016/j.bbmt.2014.07.011. Epub 2014 Jul 18.

10.

Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.

Rubinstein PG, Aboulafia DM, Zloza A.

AIDS. 2014 Feb 20;28(4):453-65. doi: 10.1097/QAD.0000000000000071. Review.

11.

Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature.

Hodowanec AC, Han A, Barker DE, Rubinstein PG, Max B.

J Int Assoc Physicians AIDS Care (Chic). 2012 Nov-Dec;11(6):345-7. doi: 10.1177/1545109712455460. Epub 2012 Aug 27. Review.

PMID:
22930795
12.

A perspective on the selection of unrelated donors and cord blood units for transplantation.

Spellman SR, Eapen M, Logan BR, Mueller C, Rubinstein P, Setterholm MI, Woolfrey AE, Horowitz MM, Confer DL, Hurley CK; National Marrow Donor Program; Center for International Blood and Marrow Transplant Research.

Blood. 2012 Jul 12;120(2):259-65. doi: 10.1182/blood-2012-03-379032. Epub 2012 May 17.

13.

Guidelines for the development and validation of new potency assays for the evaluation of umbilical cord blood.

Spellman S, Hurley CK, Brady C, Phillips-Johnson L, Chow R, Laughlin M, McMannis J, Reems JA, Regan D, Rubinstein P, Kurtzberg J; National Marrow Donor Program Cord Blood Advisory Group.

Cytotherapy. 2011 Aug;13(7):848-55. doi: 10.3109/14653249.2011.571249. Epub 2011 Mar 30.

PMID:
21449685
14.

Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue.

Zhang X, Hirai M, Cantero S, Ciubotariu R, Dobrila L, Hirsh A, Igura K, Satoh H, Yokomi I, Nishimura T, Yamaguchi S, Yoshimura K, Rubinstein P, Takahashi TA.

J Cell Biochem. 2011 Apr;112(4):1206-18. doi: 10.1002/jcb.23042.

PMID:
21312238
15.

An examination of educational gaps in the diagnosis and treatment of myelodysplastic syndromes.

Shammo JM, Foran JM, Houk A, Epstein J, Narang M, Rubinstein P, Dennison B, Latsko JM, Naganna G.

Cancer Control. 2011 Jan;18(1):65-74.

PMID:
21273982
16.

Histocompatibility and immunogenetics in cord blood transplantation.

Rubinstein P, Hillyer C.

Biol Res. 2010;43(3):339-45. doi: /S0716-97602010000300011. Epub 2010 Nov 30. Review.

17.

Durable complete remission induced by cetuximab monotherapy in a patient infected with HIV and diagnosed with recurrent squamous cell carcinoma of the head and neck.

Rubinstein PG, Lindgren V, Setty S, Yao M, Pytynia KB, Radosevich JA, Kadkol SS, Feldman LE.

J Clin Oncol. 2011 Mar 20;29(9):e222-5. doi: 10.1200/JCO.2010.32.1927. Epub 2010 Dec 28. No abstract available.

PMID:
21189379
18.

Platelet transfusions to HLA-immunized recipients: how to be or not to be matched.

Rubinstein P.

Transfusion. 2010 Nov;50(11):2292-4. doi: 10.1111/j.1537-2995.2010.02850.x. No abstract available.

PMID:
21182628
19.

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.

Brunstein CG, Miller JS, Cao Q, McKenna DH, Hippen KL, Curtsinger J, Defor T, Levine BL, June CH, Rubinstein P, McGlave PB, Blazar BR, Wagner JE.

Blood. 2011 Jan 20;117(3):1061-70. doi: 10.1182/blood-2010-07-293795. Epub 2010 Oct 15.

20.

Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries.

Cohen YC, Scaradavou A, Stevens CE, Rubinstein P, Gluckman E, Rocha V, Horowitz MM, Eapen M, Nagler A, Shpall EJ, Laughlin MJ, Daniely Y, Pacheco D, Barishev R, Olmer L, Freedman LS.

Bone Marrow Transplant. 2011 Jan;46(1):70-6. doi: 10.1038/bmt.2010.83. Epub 2010 May 3.

21.

Cord blood banking for clinical transplantation.

Rubinstein P.

Bone Marrow Transplant. 2009 Nov;44(10):635-42. doi: 10.1038/bmt.2009.281. Epub 2009 Oct 5. Review.

PMID:
19802017
22.

Cord blood banking: 'providing cord blood banking for a nation'.

Querol S, Rubinstein P, Marsh SG, Goldman J, Madrigal JA.

Br J Haematol. 2009 Oct;147(2):227-35. doi: 10.1111/j.1365-2141.2009.07818.x. Review.

PMID:
19796272
23.

Extracellular DNA in cord blood plasma and applications in cord blood banking for sample identification.

Albano MS, Scaradavou A, Stevens CE, Rubinstein P.

Transfusion. 2009 Aug;49(8):1685-91. doi: 10.1111/j.1537-2995.2009.02168.x.

PMID:
19392775
24.

Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.

Hippen KL, Harker-Murray P, Porter SB, Merkel SC, Londer A, Taylor DK, Bina M, Panoskaltsis-Mortari A, Rubinstein P, Van Rooijen N, Golovina TN, Suhoski MM, Miller JS, Wagner JE, June CH, Riley JL, Blazar BR.

Blood. 2008 Oct 1;112(7):2847-57. doi: 10.1182/blood-2008-01-132951. Epub 2008 Jul 21.

25.

Delayed hemolysis after intravenous anti-D immune globulin infusion in a patient with idiopathic thrombocytopenic purpura.

Rubinstein PG, Chen YH.

Am J Hematol. 2008 Aug;83(8):684-5. doi: 10.1002/ajh.21201. No abstract available.

26.
27.

Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.

Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A, Loberiza FR, Champlin RE, Klein JP, Horowitz MM, Wagner JE.

Lancet. 2007 Jun 9;369(9577):1947-54.

PMID:
17560447
28.

Umbilical cord blood collection: do patients really understand?

Fox NS, Stevens C, Ciubotariu R, Rubinstein P, McCullough LB, Chervenak FA.

J Perinat Med. 2007;35(4):314-21.

PMID:
17511596
29.

Umbilical cord blood transplantation and cytomegalovirus: Posttransplantation infection and donor screening.

Albano MS, Taylor P, Pass RF, Scaradavou A, Ciubotariu R, Carrier C, Dobrila L, Rubinstein P, Stevens CE.

Blood. 2006 Dec 15;108(13):4275-82. Epub 2006 Aug 22.

30.

Comparative quantification of umbilical cord blood CD34+ and CD34+ bright cells using the ProCount-BD and ISHAGE protocols.

Pranke P, Hendrikx J, Alespeiti G, Nardi N, Rubinstein P, Visser J.

Braz J Med Biol Res. 2006 Jul;39(7):901-6.

31.

Why cord blood?

Rubinstein P.

Hum Immunol. 2006 Jun;67(6):398-404. Epub 2006 Mar 30. Review.

PMID:
16728260
32.

Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months.

Eapen M, Rubinstein P, Zhang MJ, Camitta BM, Stevens C, Cairo MS, Davies SM, Doyle JJ, Kurtzberg J, Pulsipher MA, Ortega JJ, Scaradavou A, Horowitz MM, Wagner JE.

J Clin Oncol. 2006 Jan 1;24(1):145-51.

PMID:
16382124
33.

Immunophenotype of hematopoietic stem cells from placental/umbilical cord blood after culture.

Pranke P, Hendrikx J, Debnath G, Alespeiti G, Rubinstein P, Nardi N, Visser J.

Braz J Med Biol Res. 2005 Dec;38(12):1775-89. Epub 2005 Nov 9.

34.

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.

Laughlin MJ, Eapen M, Rubinstein P, Wagner JE, Zhang MJ, Champlin RE, Stevens C, Barker JN, Gale RP, Lazarus HM, Marks DI, van Rood JJ, Scaradavou A, Horowitz MM.

N Engl J Med. 2004 Nov 25;351(22):2265-75.

35.

PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome.

Hernández-Guerra M, Turnes J, Rubinstein P, Olliff S, Elias E, Bosch J, García-Pagán JC.

Hepatology. 2004 Nov;40(5):1197-202.

PMID:
15486923
36.

Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.

Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P, Allison-Thacker J, Wood S, Wenger DA, Rubinstein P, Hopwood JJ, Krivit W, Kurtzberg J.

N Engl J Med. 2004 May 6;350(19):1960-9.

37.

Obstetric predictors of placental/umbilical cord blood volume for transplantation.

Jones J, Stevens CE, Rubinstein P, Robertazzi RR, Kerr A, Cabbad MF.

Am J Obstet Gynecol. 2003 Feb;188(2):503-9.

PMID:
12592263
38.

Hematopoietic recovery after unrelated umbilical cord-blood allogeneic transplantation in adults treated with in vivo stem cell factor (R-MetHuSCF) and filgrastim administration.

Wadhwa PD, Lazarus HM, Koc ON, Jaroscak J, Woo D, Stevens CE, Rubinstein P, Laughlin MJ.

Leuk Res. 2003 Mar;27(3):215-20.

PMID:
12537973
39.

Placental/umbilical cord blood for unrelated-donor bone marrow reconstitution: relevance of nucleated red blood cells.

Stevens CE, Gladstone J, Taylor PE, Scaradavou A, Migliaccio AR, Visser J, Dobrila NL, Carrier C, Cabbad M, Wernet P, Kurtzberg J, Rubinstein P.

Blood. 2002 Oct 1;100(7):2662-4.

40.

[Spontaneous bacterial peritonitis in hepatic cirrhosis with ascites: incidence, bacteriology and mortality in Uruguay].

Rubinstein P, Morales M, Pandiani A, Bagattini JC.

Acta Gastroenterol Latinoam. 2001 Oct;31(4):307-12. Spanish.

PMID:
11766541
41.

HLA matching for bone marrow transplantation--how much is enough?

Rubinstein P.

N Engl J Med. 2001 Dec 20;345(25):1842-4. No abstract available.

PMID:
11752363
42.

Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells.

Kanovsky M, Raffo A, Drew L, Rosal R, Do T, Friedman FK, Rubinstein P, Visser J, Robinson R, Brandt-Rauf PW, Michl J, Fine RL, Pincus MR.

Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12438-43. Epub 2001 Oct 16.

43.

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE, Gerson SL, Lazarus HM, Cairo M, Stevens CE, Rubinstein P, Kurtzberg J.

N Engl J Med. 2001 Jun 14;344(24):1815-22.

44.

Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C, Remberger M, Michel G, Arcese W, Dallorso S, Tiedemann K, Busca A, Chan KW, Kato S, Ortega J, Vowels M, Zander A, Souillet G, Oakill A, Woolfrey A, Pay AL, Green A, Garnier F, Ionescu I, Wernet P, Sirchia G, Rubinstein P, Chevret S, Gluckman E.

Blood. 2001 May 15;97(10):2962-71.

45.

Graft-versus-leukemia-induced complete remission following unrelated umbilical cord blood transplantation for acute leukemia.

Howrey RP, Martin PL, Driscoll T, Szabolcs P, Kelly T, Shpall EJ, Bearman SI, Slat-Vasquez V, Rubinstein P, Stevens CE, Kurtzberg J.

Bone Marrow Transplant. 2000 Dec;26(11):1251-4.

46.

The New York Blood Center's Placental/Umbilical Cord Blood Program. Experience with a 'new' source of hematopoietic stem cells for transplantation.

Rubinstein P, Stevens CE.

Ernst Schering Res Found Workshop. 2001;(33):47-70. Review. No abstract available.

PMID:
11105253
47.

Placental blood for bone marrow replacement: the New York Blood Center's program and clinical results.

Rubinstein P, Stevens CE.

Baillieres Best Pract Res Clin Haematol. 2000 Dec;13(4):565-84. Review.

PMID:
11102277
48.
50.

Unrelated placental blood in marrow transplantation.

Kurtzberg J, Martin P, Chao N, Stevens C, Rubinstein P.

Stem Cells. 2000;18(2):153-4. No abstract available.

Supplemental Content

Loading ...
Support Center